SLC6A3 and attention deficit-hyperactivity disorder: Dopaminergic dysfunction in ADHD has been supported through animal studies and pharmacological treatments, like methylphenidate that blocks DA transporters at therapeutic doses, which could be linked to why ADHD patients are vulnerable to drug dependence (Véronneau-Veilleux et al., 2022).